Cargando…

High-Level Cross-Resistance to Didanosine Observed in South African Children Failing an Abacavir- or Stavudine-Based 1(st)-Line Regimen

BACKGROUND: The knowledge-base of emerging drug resistance profiles in children exposed to abacavir-based antiretroviral regimens in South Africa is very limited. This study investigated the suitability of didanosine-based 2(nd)-line regimens for children in the context of antiretroviral drug resist...

Descripción completa

Detalles Bibliográficos
Autores principales:	Steegen, Kim, Levin, Leon, Ketseoglou, Irene, Bronze, Michelle, Papathanasopoulos, Maria A., Carmona, Sergio, Stevens, Wendy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016228/ https://www.ncbi.nlm.nih.gov/pubmed/24816790 http://dx.doi.org/10.1371/journal.pone.0097067

Ejemplares similares

Poor Efficacy and Tolerability of Stavudine, Didanosine, and Efavirenz-based Regimen in Treatment-Naive Patients in Senegal
por: Canestri, Anna, et al.
Publicado: (2007)

Abacavir, efavirenz, didanosine, with or without hydroxyurea, in HIV-infected adults failing initial nucleoside/protease inhibitor-containing regimens
por: Swindells, Susan, et al.
Publicado: (2005)

High Prevalence of the K65R Mutation in HIV-1 Subtype C Infected Patients Failing Tenofovir-Based First-Line Regimens in South Africa
por: Skhosana, Lindiwe, et al.
Publicado: (2015)

Interactions of Tenofovir, Lamivudine, Abacavir and Didanosine in Primary Human Cells
por: Janneh, Omar, et al.
Publicado: (2011)

Moderate Levels of Pre-Treatment HIV-1 Antiretroviral Drug Resistance Detected in the First South African National Survey
por: Steegen, Kim, et al.
Publicado: (2016)

Abacavir, zidovudine, or stavudine as paediatric tablets for African HIV-infected children (CHAPAS-3): an open-label, parallel-group, randomised controlled trial
por: Mulenga, Veronica, et al.
Publicado: (2016)

Preparing for the next pandemic: Lessons from rapid scale-up of SARS-CoV-2 testing in a South African high-throughput automated HIV molecular laboratory
por: Hans, Lucia, et al.
Publicado: (2021)

Bioretrosynthetic construction of a didanosine biosynthetic pathway
por: Birmingham, William R., et al.
Publicado: (2014)

A retrospective case-cohort study comparing treatment outcomes in abacavir versus stavudine containing first line antiretroviral treatment regimens in children <3yrs old, at a paediatric programme based in Soweto, South Africa
por: Cassim, Haseena, et al.
Publicado: (2017)

Can We Improve Stavudine's Safety Profile in Children? Pharmacokinetics of Intracellular Stavudine Triphosphate with Reduced Dosing
por: Innes, Steve, et al.
Publicado: (2018)

HIV-1 Phenotypic Reverse Transcriptase Inhibitor Drug Resistance Test Interpretation Is Not Dependent on the Subtype of the Virus Backbone
por: Bronze, Michelle, et al.
Publicado: (2012)

Post-dispensing stability surveillance: Stavudine
por: Naidoo, Kamsaladevi K., et al.
Publicado: (2009)

Renal impairment after switching from stavudine/lamivudine to tenofovir/lamivudine in NNRTI-based antiretroviral regimens
por: Manosuthi, Weerawat, et al.
Publicado: (2010)

Analysis of in vivo absorption of didanosine tablets in male adult dogs by HPLC
por: Severino, Patrícia, et al.
Publicado: (2012)

The susceptibility of five African Anopheles species to Anabaena PCC 7120 expressing Bacillus thuringiensis subsp. israelensis mosquitocidal cry genes
por: Ketseoglou, Irene, et al.
Publicado: (2012)

Formulation and evaluation of floating matrix tablet of stavudine
por: Prajapati, Pankaj H, et al.
Publicado: (2012)

Minimal Cross-resistance to Tenofovir in Children and Adolescents Failing ART Makes Them Eligible for Tenofovir-Lamivudine-Dolutegravir Treatment
por: Steegen, Kim, et al.
Publicado: (2022)

Pharmacogenetic variation influences sensory neuropathy occurrence in Southern Africans treated with stavudine-containing antiretroviral therapy
por: Moketla, Marvin Blessings, et al.
Publicado: (2018)

A Case of Non-Cirrhotic Portal Hypertension Associated With Chronic Didanosine Therapy
por: Stotts, Matthew, et al.
Publicado: (2015)

Formulation and Evaluation of Controlled Release Floating Microballoons of Stavudine
por: Vidyadhara, Suryadevara, et al.
Publicado: (2015)

A longitudinal study of stavudine-associated toxicities in a large cohort of South African HIV infected subjects
por: Menezes, Colin N, et al.
Publicado: (2011)

Abacavir forms novel cross-linking abacavir protein adducts in patients
por: Meng, Xiaoli, et al.
Publicado: (2014)

Resistance in Patients Failing Integrase Strand Transfer Inhibitors: A Call to Replace Raltegravir With Dolutegravir in Third-Line Treatment in South Africa
por: Steegen, Kim, et al.
Publicado: (2019)

Preparation of gastro-resistant pellets containing chitosan microspheres for improvement of oral didanosine bioavailability
por: Severino, Patrícia, et al.
Publicado: (2012)

Efficacious Preclinical Repurposing of the Nucleoside Analogue Didanosine against COVID-19 Polymerase and Exonuclease
por: Rabie, Amgad M.
Publicado: (2022)

Portal Hypertension Due to Hepatoportal Sclerosis in an HIV-Positive Patient Secondary to Didanosine Use
por: Phrathep, Davong D, et al.
Publicado: (2023)

Increased Risk of Q151M and K65R Mutations in Patients Failing Stavudine-Containing First-Line Antiretroviral Therapy in Cambodia
por: Nouhin, Janin, et al.
Publicado: (2013)

A Case of Lactic Acidosis Caused by Stavudine in an AIDS Patient
por: Cho, Byoung Chul, et al.
Publicado: (2004)

A case of nodular regenerative hyperplasia in a patient who had been taking didanosine
por: Jackson, C, et al.
Publicado: (2010)

Scoring Methods for Building Genotypic Scores: An Application to Didanosine Resistance in a Large Derivation Set
por: Houssaini, Allal, et al.
Publicado: (2013)

Insulin resistance in people living with HIV is associated with exposure to thymidine analogues and/or didanosine and prior immunodeficiency
por: Høgh, Julie, et al.
Publicado: (2022)

Virological outcomes in ARV-naïve patients switching or not from a first successful boosted PI-regimen to efavirenz, nevirapine or abacavir regimens
por: Bommenel, T, et al.
Publicado: (2010)

Stavudine Toxicity in Adult Longer-Term ART Patients in Blantyre, Malawi
por: van Oosterhout, Joep J., et al.
Publicado: (2012)

Stavudine induced acute necrotizing pancreatitis with tetany in a pediatric patient
por: Patel, Mahendra K., et al.
Publicado: (2012)

Abacavir-induced liver toxicity
por: Pezzani, Maria Diletta, et al.
Publicado: (2016)

Toxic intracellular anabolite levels of tenofovir and didanosine causing a steep CD4-cell decline
por: de Jong, E, et al.
Publicado: (2010)

Repurposing Didanosine as a Potential Treatment for COVID-19 Using Single-Cell RNA Sequencing Data
por: Alakwaa, Fadhl M.
Publicado: (2020)

Molecular characterisation of rifampicin-resistant Mycobacterium tuberculosis strains from Malawi
por: Chikaonda, Tarsizio, et al.
Publicado: (2017)

Formulation and Optimization of Sustained Release Stavudine Microspheres Using Response Surface Methodology
por: Dey, Sanjay, et al.
Publicado: (2011)

Oral Disintegration Tablets of Stavudine for HIV Management: A New Technological Approach
por: Sankar, V., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_d6p0q9a9oac4080cl1l68jng62